نتایج جستجو برای: copper radiopharmaceuticals

تعداد نتایج: 86023  

2017
Mark S. Jacobson Raymond A. Steichen Patrick J. Peller

References .......................................................................... 27 Abstract The vast majority of PET radiopharmaceuticals today are cyclotron produced. Carbon-11 (C), Nitrogen-13 (N), Oxygen-15 (O) products are created for in-house use only due to their short half-lives. The longer half-life of Fluorine-18 means that F-labeled PET radiotracers can be widely distributed. Pr...

Journal: :In vivo 2005
Michael F Giblin Bhadrasetty Veerendra Charles J Smith

Radiolabeled, receptor-specific peptides are becoming increasingly popular as targeting vectors for the design and development of new diagnostic and therapeutic radiopharmaceuticals. The over-expression of functioning receptors on a variety of human cancers makes this method of drug development a viable tool for tumor targeting in vivo. This review describes some of the more recent efforts that...

Journal: :Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti 2012
J Adam K Bolcak J Kaderavek F Kuzel

The existence of the cyclotron & PET centre of UJV Rez, a.s., at Masaryk Memorial Cancer Institute allows the Masaryk Memorial Cancer Institute and RECAMO researchers to engage in the research, development and application of new radiopharmaceuticals including compounds labelled by short-living positron emitters (especially [11C]). Currently, a [11C]-labelled tracer, L-[methyl-11C]methionine, is...

2015
C. C. D. Kulathilake M. Jayatilake T. Takahashi

The myocardium is composed of specialized muscle which relies mainly on fatty acid and sugar metabolism and it is widely contribute to the heart functioning. The changes of the cardiac energy-producing system during heart failure have been proved using autoradiography techniques. This study focused on evaluating sugar and fatty acid metabolism in myocardium as cardiac energy getting system usin...

Journal: :Dalton transactions 2014
Brett M Paterson Peter Roselt Delphine Denoyer Carleen Cullinane David Binns Wayne Noonan Charmaine M Jeffery Roger I Price Jonathan M White Rodney J Hicks Paul S Donnelly

The use of copper radioisotopes in cancer diagnosis and radionuclide therapy is possible using chelators that are capable of binding Cu(II) with sufficient stability in vivo to provide high tumour-to-background contrast. Here we report the design and synthesis of a new bifunctional chelator, 5-(8-methyl-3,6,10,13,16,19-hexaaza-bicyclo[6.6.6]icosan-1-ylamino)-5-oxopentanoic acid (MeCOSar), that ...

Journal: :Molecules 2014
Shuanglong Liu Zibo Li Peter S Conti

A new class of multifunctionalized sarcophagine derivatives was synthesized for 64Cu chelation. The platform developed in this study could have broad applications in 64Cu-radiopharmaceuticals.

Journal: :Brazilian Archives of Biology and Technology 2005

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید